{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:04:06Z","timestamp":1789761846948,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.urolonc.2026.07.012","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:47:13Z","timestamp":1785556033000},"page":"814-823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intraductal carcinoma of the prostate does not independently predict adverse outcomes after radical prostatectomy: A National Cancer Database analysis"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0947-407X","authenticated-orcid":false,"given":"Ryan M.","family":"Antar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4562-4824","authenticated-orcid":false,"given":"Vincent E.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0682-3465","authenticated-orcid":false,"given":"William S.","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4071-3094","authenticated-orcid":false,"given":"Neil","family":"Mendhiratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2423-072X","authenticated-orcid":false,"given":"Michael J.","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2026.07.012_bib0001","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.eururo.2017.03.013","article-title":"Systematic review links the prevalence of intraductal carcinoma of the prostate to prostate cancer risk categories","volume":"72","author":"Porter","year":"2017","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.012_bib0002","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.07.012_bib0003","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/JU.0000000000001290","article-title":"The prognostic impact of intraductal carcinoma of the prostate: a systematic review and meta-analysis","volume":"204","author":"Miura","year":"2020","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/j.urolonc.2026.07.012_bib0004","doi-asserted-by":"crossref","first-page":"673e9","DOI":"10.1016\/j.urolonc.2017.08.015","article-title":"Population-based study of the incidence and survival for intraductal carcinoma of the prostate","volume":"35","author":"Dinerman","year":"2017","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.012_bib0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/aja.aja_21_20","article-title":"The presence of intraductal carcinoma of the prostate is closely associated with poor prognosis: a systematic review and meta-analysis","volume":"23","author":"Zhang","year":"2021","journal-title":"Asian J Androl"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.012_bib0006","doi-asserted-by":"crossref","first-page":"48e11","DOI":"10.1016\/j.urolonc.2022.09.025","article-title":"The rising incidence of ductal adenocarcinoma and intraductal carcinoma of the prostate: diagnostic accuracy of biopsy, MRI-visibility, and outcomes","volume":"41","author":"Pahouja","year":"2023","journal-title":"Urol Oncol"},{"issue":"11","key":"10.1016\/j.urolonc.2026.07.012_bib0007","doi-asserted-by":"crossref","first-page":"469","DOI":"10.6004\/jnccn.2025.0052","article-title":"Prostate Cancer, Version 3.2026, NCCN Clinical Practice Guidelines In oncology","volume":"23","author":"Spratt","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.012_bib0008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/his.70046","article-title":"The genitourinary pathology society and international society of urological pathology joint expert consultation recommendations on intraductal carcinoma of the prostate","volume":"88","author":"Shah","year":"2026","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.urolonc.2026.07.012_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers16091650","article-title":"Clinical management of intraductal carcinoma of the prostate","volume":"16","author":"Wasinger","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.urolonc.2026.07.012_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers15051372","article-title":"Prostate cancer morphologies: cribriform pattern and intraductal carcinoma relations to adverse pathological and clinical outcomes-systematic review and meta-analysis","volume":"15","author":"Osiecki","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"22","key":"10.1016\/j.urolonc.2026.07.012_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers15225319","article-title":"Intraductal carcinoma of the prostate: to grade or not to grade","volume":"15","author":"Surintrspanont","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.urolonc.2026.07.012_bib0012","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1111\/cas.15392","article-title":"Clinical significance of IDC-P as predictive factor after intensity-modulated radiation therapy","volume":"113","author":"Aizawa","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.urolonc.2026.07.012_bib0013","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.urology.2025.01.061","article-title":"Prognostic value of cribriform and intraductal carcinoma in grade group 2 prostate cancer with and without synchronous nodal metastases at radical prostatectomy: results from a case-control matched, multicenter study","volume":"199","author":"de Barros","year":"2025","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.urolonc.2026.07.012_bib0014","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ejca.2014.03.009","article-title":"Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort","volume":"50","author":"Trudel","year":"2014","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2026.07.012_bib0015","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.clgc.2023.03.010","article-title":"Associations between intraductal prostate cancer and metastases following radical prostatectomy in men with prostate cancer in the Veterans Affairs database","volume":"21","author":"Nelson","year":"2023","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2026.07.012_bib0016","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/PAS.0000000000002480","article-title":"Intraductal carcinoma of the prostate with a solid nest pattern may Be more aggressive than gleason grade 5 conventional prostatic adenocarcinoma","volume":"50","author":"Shi","year":"2026","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2026.07.012_bib0017","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.humpath.2023.06.011","article-title":"Comedonecrosis within conventional prostatic adenocarcinoma vs. intraductal carcinoma of the prostate: their clinical significance is not comparable","volume":"138","author":"Wang","year":"2023","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.07.012_bib0018","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.urolonc.2024.01.037","article-title":"Ductal, intraductal, and cribriform carcinoma of the prostate: molecular characteristics and clinical management","volume":"42","author":"Shi","year":"2024","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.012_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.70238","article-title":"Molecular alteration profiles characterize intraductal carcinoma of the prostate","volume":"132","author":"Dudipala","year":"2026","journal-title":"Cancer"},{"issue":"16_suppl","key":"10.1016\/j.urolonc.2026.07.012_bib0020","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1200\/JCO.2023.41.16_suppl.5024","article-title":"Clinical implications of molecular alterations in intraductal carcinoma of the prostate","volume":"41","author":"Miron","year":"2023","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.07.012_bib0021","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/pros.23484","article-title":"Intraductal\/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer","volume":"78","author":"Isaacsson Velho","year":"2018","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.urolonc.2026.07.012_bib0022","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/bju.15530","article-title":"Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate","volume":"129","author":"Zhao","year":"2022","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.012_bib0023","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1186\/s12885-025-15001-2","article-title":"Evaluation of intraductal carcinoma and invasive cribriform carcinoma as predictors of genetic mutations in systemic treatment-naive prostate cancer patients","volume":"25","author":"Lee","year":"2025","journal-title":"BMC Cancer"},{"issue":"6_suppl","key":"10.1016\/j.urolonc.2026.07.012_bib0024","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.2022.40.6_suppl.268","article-title":"A genomic classifier for prostate cancer correlates with adverse pathologic features: transcriptomic features of cribriform and intraductal carcinoma of the prostate","volume":"40","author":"Lone","year":"2022","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.07.012_bib0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/JU.0000000000003850","article-title":"Intraductal prostate cancer affinity for lymphatic-predominant metastases through (18)F-DCFPyL\u2012prostate-specific membrane antigen\u2012positron emission tomography\/CT scans in pretreatment prostate cancer patients","volume":"211","author":"Bernardino","year":"2024","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.07.012_bib0026","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/JU.0000000000004734","volume":"214","author":"Chen","year":"2025","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.07.012_bib0027","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4103\/aja.aja_117_19","article-title":"Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer","volume":"22","author":"Zhu","year":"2020","journal-title":"Asian J Androl"},{"issue":"6","key":"10.1016\/j.urolonc.2026.07.012_bib0028","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14099","article-title":"Prognostic value of intraductal carcinoma for adjuvant radiotherapy candidates after radical prostatectomy","volume":"75","author":"Karakoc","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"10","key":"10.1016\/j.urolonc.2026.07.012_bib0029","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/pros.23513","article-title":"The impact of intraductal carcinoma of the prostate on the site and timing of recurrence and cancer-specific survival","volume":"78","author":"Trinh","year":"2018","journal-title":"Prostate"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926006046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926006046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:11:53Z","timestamp":1789758713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926006046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1078143926006046"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.07.012","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraductal carcinoma of the prostate does not independently predict adverse outcomes after radical prostatectomy: A National Cancer Database analysis","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}